Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate Cancer

Cécile Vicier; Felix Y. Feng; Karim Fizazi

doi:10.1016/j.euf.2019.01.015

Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate Cancer

Cécile Vicier, Felix Y. Feng, Karim Fizazi

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

1 Citation (Scopus)

Résumé

One of the standard management options for high-risk localized prostate cancer is radiotherapy combined with long-term androgen deprivation therapy. Trials involving chemotherapy or next-generation hormone therapies in combination with a local treatment are ongoing for this specific subgroup.

langue originale	Anglais
Pages (de - à)	168-170
Nombre de pages	3
journal	European Urology Focus
Volume	5
Numéro de publication	2
Les DOIs	https://doi.org/10.1016/j.euf.2019.01.015
état	Publié - 1 mars 2019

Accès au document

10.1016/j.euf.2019.01.015

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ed7b664f8ccc4fe28bcae95c3d9e1a37,

title = "Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate Cancer",

abstract = "One of the standard management options for high-risk localized prostate cancer is radiotherapy combined with long-term androgen deprivation therapy. Trials involving chemotherapy or next-generation hormone therapies in combination with a local treatment are ongoing for this specific subgroup.",

author = "C{\'e}cile Vicier and Feng, {Felix Y.} and Karim Fizazi",

note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology",

year = "2019",

month = mar,

day = "1",

doi = "10.1016/j.euf.2019.01.015",

language = "English",

volume = "5",

pages = "168--170",

journal = "European Urology Focus",

issn = "2405-4569",

number = "2",

}

TY - JOUR

T1 - Overview of Systemic Therapy Augmenting Management of High-risk Localized Prostate Cancer

AU - Vicier, Cécile

AU - Feng, Felix Y.

AU - Fizazi, Karim

PY - 2019/3/1

Y1 - 2019/3/1

N2 - One of the standard management options for high-risk localized prostate cancer is radiotherapy combined with long-term androgen deprivation therapy. Trials involving chemotherapy or next-generation hormone therapies in combination with a local treatment are ongoing for this specific subgroup.

AB - One of the standard management options for high-risk localized prostate cancer is radiotherapy combined with long-term androgen deprivation therapy. Trials involving chemotherapy or next-generation hormone therapies in combination with a local treatment are ongoing for this specific subgroup.

UR - http://www.scopus.com/inward/record.url?scp=85061087294&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2019.01.015

DO - 10.1016/j.euf.2019.01.015

M3 - Article

C2 - 30745118

AN - SCOPUS:85061087294

SN - 2405-4569

VL - 5

SP - 168

EP - 170

JO - European Urology Focus

JF - European Urology Focus

IS - 2

ER -